Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, Marius Pharmaceuticals is raising $6,006,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Om Dhingra played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Marius Pharmaceuticals
Patient-centric healthcare company focusing on therapies designed for hypogonadism. Our mission is to better the functional lives of hypogonadal patients by ensuring adequate levels of testosterone and enhance patient care through personalization. Marius is a patient centric healthcare company focusing on therapies designed for hypogonadism or testosterone deficiency. The company’s mission is to improve the functional lives of patients by reducing the downstream effects of testosterone deficiency which include increased inflammation and fatigue.

To learn more about Marius Pharmaceuticals, visit http://www.mariuspharma.com/

Contact:
Om Dhingra, Chief Executive Officer
919-719-6376
https://www.linkedin.com/in/om-dhingra-9840ab1b5/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved